Edgar López‐López

1.2k total citations
38 papers, 597 citations indexed

About

Edgar López‐López is a scholar working on Computational Theory and Mathematics, Molecular Biology and Pharmacology. According to data from OpenAlex, Edgar López‐López has authored 38 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Computational Theory and Mathematics, 23 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Edgar López‐López's work include Computational Drug Discovery Methods (24 papers), Metabolomics and Mass Spectrometry Studies (6 papers) and Epigenetics and DNA Methylation (5 papers). Edgar López‐López is often cited by papers focused on Computational Drug Discovery Methods (24 papers), Metabolomics and Mass Spectrometry Studies (6 papers) and Epigenetics and DNA Methylation (5 papers). Edgar López‐López collaborates with scholars based in Mexico, United States and Germany. Edgar López‐López's co-authors include José L. Medina‐Franco, J. Jesús Naveja, Fernando D. Prieto‐Martínez, Jürgen Bajorath, Norberto Sánchez‐Cruz, Fernanda I. Saldívar‐González, Eli Fernández‐de Gortari, Bárbara I. Díaz‐Eufracio, Carlos M. Cerda‐García‐Rojas and Ramón Alain Miranda‐Quintana and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecules and Chemical Science.

In The Last Decade

Edgar López‐López

34 papers receiving 588 citations

Peers

Edgar López‐López

CTM

PHARM

José Teófilo Moreira‐Filho Brazil

Stefan Bietz Germany

Agnes Meyder Germany

Tailong Lei China

Sivakumar Prasanth Kumar India

Peiwen Di China

Simon Cross Italy

Rafael Gozalbes Spain

Fernanda I. Saldívar‐González Mexico

Markus Sitzmann United States

José Teófilo Moreira‐Filho Brazil

Edgar López‐López

350 ×1.0

CTM

268 ×0.9

124 ×1.2

76 ×0.9

PHARM

83 ×1.3

Citations per year, relative to Edgar López‐López Edgar López‐López (= 1×) peers José Teófilo Moreira‐Filho

Countries citing papers authored by Edgar López‐López

Since Specialization

Citations

This map shows the geographic impact of Edgar López‐López's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edgar López‐López with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edgar López‐López more than expected).

Fields of papers citing papers by Edgar López‐López

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edgar López‐López. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edgar López‐López. The network helps show where Edgar López‐López may publish in the future.

Co-authorship network of co-authors of Edgar López‐López

This figure shows the co-authorship network connecting the top 25 collaborators of Edgar López‐López. A scholar is included among the top collaborators of Edgar López‐López based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edgar López‐López. Edgar López‐López is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

López‐López, Edgar, et al.. (2025). Exploring and expanding the chemical multiverse of peptides. Chemical Science. 17(3). 1461–1479.

López‐López, Edgar, et al.. (2025). A Covalent and Modulable Inhibitor of the Tubulin‐Microtubule System: Insights Into the Mechanism of Cacalol. Chemical Biology & Drug Design. 106(3). e70165–e70165. 1 indexed citations

López‐López, Edgar, et al.. (2025). Implicaciones bioéticas en el uso de la biotecnología para la conservación de agaves en el estado de Hidalgo. BIOtecnia. 27. e2432–e2432.

López‐López, Edgar, et al.. (2025). Structure–Property Associations: Breaking Paradigms for Linking Chemical Structures and Biological Properties in Drug Discovery. ChemMedChem. 21(1). e202500847–e202500847.

López‐López, Edgar, et al.. (2024). Molecular similarity: Theory, applications, and perspectives. SHILAP Revista de lepidopterología. 2(2). 100077–100077. 12 indexed citations

Martínez‐Mayorga, Karina, et al.. (2024). The pursuit of accurate predictive models of the bioactivity of small molecules. Chemical Science. 15(6). 1938–1952. 17 indexed citations

López‐López, Edgar & José L. Medina‐Franco. (2024). Toward structure–multiple activity relationships (SMARts) using computational approaches: A polypharmacological perspective. Drug Discovery Today. 29(7). 104046–104046. 9 indexed citations

Medina‐Franco, José L., et al.. (2024). Rethinking the 'best method' paradigm: The effectiveness of hybrid and multidisciplinary approaches in chemoinformatics. SHILAP Revista de lepidopterología. 6. 100117–100117. 2 indexed citations

López‐López, Edgar, et al.. (2023). Consensus docking aid to model the activity of an inhibitor of DNA methyltransferase 1 inspired by de novo design. SHILAP Revista de lepidopterología. 3. 6 indexed citations

10.

López‐López, Edgar & José L. Medina‐Franco. (2023). Towards Decoding Hepatotoxicity of Approved Drugs through Navigation of Multiverse and Consensus Chemical Spaces. Biomolecules. 13(1). 176–176. 8 indexed citations

11.

López‐López, Edgar, et al.. (2023). Yin-yang in drug discovery: rethinking de novo design and development of predictive models. SHILAP Revista de lepidopterología. 3. 5 indexed citations

12.

López‐López, Edgar, et al.. (2023). Mapping the structure–activity landscape of non-canonical peptides with MAP4 fingerprinting. Digital Discovery. 2(5). 1494–1505. 5 indexed citations

13.

López‐López, Edgar, et al.. (2023). Exploring activity landscapes with extended similarity: is Tanimoto enough?. Molecular Informatics. 42(7). e2300056–e2300056. 11 indexed citations

14.

López‐López, Edgar, Eli Fernández‐de Gortari, & José L. Medina‐Franco. (2022). Yes SIR! On the structure–inactivity relationships in drug discovery. Drug Discovery Today. 27(8). 2353–2362. 35 indexed citations

15.

Medina‐Franco, José L., Edgar López‐López, Lena Ruíz-Azuara, et al.. (2022). Bridging informatics and medicinal inorganic chemistry: Toward a database of metallodrugs and metallodrug candidates. Drug Discovery Today. 27(5). 1420–1430. 22 indexed citations

16.

Bajorath, Jürgen, Miquel Duran‐Frigola, Eli Fernández‐de Gortari, et al.. (2022). Chemoinformatics and artificial intelligence colloquium: progress and challenges in developing bioactive compounds. Journal of Cheminformatics. 14(1). 82–82. 27 indexed citations

17.

Medina‐Franco, José L., et al.. (2022). Chemical Multiverse: An Expanded View of Chemical Space. Molecular Informatics. 41(11). e2200116–e2200116. 43 indexed citations

18.

López‐López, Edgar, Obdulia Rabal, Julen Oyarzábal, & José L. Medina‐Franco. (2020). Towards the understanding of the activity of G9a inhibitors: an activity landscape and molecular modeling approach. Journal of Computer-Aided Molecular Design. 34(6). 659–669. 18 indexed citations

19.

López‐López, Edgar, et al.. (2020). In silico tools to study molecular targets of neglected diseases: inhibition of TcSir2rp3, an epigenetic enzyme of Trypanosoma cruzi. Advances in protein chemistry and structural biology. 122. 203–229. 15 indexed citations

20.

Medina‐Franco, José L., J. Jesús Naveja, & Edgar López‐López. (2019). Reaching for the bright StARs in chemical space. Drug Discovery Today. 24(11). 2162–2169. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact